Diese Seite ist nicht auf Deutsch verfügbar. Hier gelangen Sie zur deutschen Homepage.

This page isn’t available in English. Here, you’ll get to the English homepage.


Esta página no está disponible en español - Aquí podrá acceder a la página web en español.

Questa pagina non è disponibile in italiano. Qui si accede alla homepage in italiano.

Cette page n’est pas disponible en français. Ce lien vous conduira à la page d'accueil en français.

해당 페이지는 한국어가 지원되지 않습니다. 이 곳을 클릭하시면 한국어 버전 홈페이지로 이동하게 됩니다.

Niels Hölder

Contact vCard

P +49 (0) 89 92 40 90

Arabellastraße 30
81925 Munich

For security reasons we give you the possibility to communicate with Niels Hölder in an encrypted form by e-mail.

Patent Litigation & Licensing

Niels Hölder


Dr. jur., LL.M. Intellectual Property Law (Dresden/Exeter), Attorney-at-law, Certified Specialist IP lawyer


Languages: English, German


Patent litigation, licensing, unfair competition disputes, supplementary protection certificates, pharmaceutical data protection and market exclusivity.


Patent litigation nowadays requires more insight and creative Imagination than ever before (Leaders League Intelligence Report & Directory Series 2017); A guide to opting out of the UPC (Europe IP Focus 2017); Pharma and Biotech Patent Litigation (Corporate Disputes Magazine, 2014); Pallet Container II, Federal Court of Justice (Kluwer Patent Cases, 2012); Equivalence and Relevant Prior Art – What Does the Person Skilled in the Art Know? in: Liber Amicorum Guntram Rahn, 2011, Liability for Acts Committed Abroad in: Overprotection by Means of Intellectual Property?, 2009, The Doctor's Freedom of Prescription – an Illusion?* in: Liber Amicorum Peter Mes, 2009, EPC 2000 and its impact on second medical use claims* in: Liber Amicorum Joseph Straus, 2009, Early entry comes at a price* (Patent World 5/2007, 11), Replacement Parts and Exhaustion (GRUR 2007, 96), Indirect Patent Infringement: Latest Developments in Germany* ((EIPR 2006, 480), Exogenous Equals Endogenous? Claim Construction After the Amgen Decision (IIC 2006, 662-669), Patentability of diagnostic methods* (Pharmaceutical Law Insight 6/2006, 4), Utility models for second medical use inventions in Germany* (Patent World 6/2006, 22) , SPCs for combinations of active ingredients* (Patent World 3/2006, 13), 2nd medical use claims at the EPO* (Patent World 2/2006, 12), Indirect Infringement and Exhaustion (GRUR 2005, 20/AIPPI Japan 3/2004, 10/IIC 2005, 889), Jurisdiction over co-defendants in European patent litigation (Mitt. 2005, 208), Patent licenses in insolvency proceedings* (GRUR 2004, 743 and 803), Cross-border Enforcement of European Patents (2004), Enforcement of foreign IP rights in the UK (ICCLR 2002, 30 and 80) - *co-author. Regular lectures on patent law and civil procedure.

Professional memberships



Study of law at the Free University of Berlin 1992 – 1997, legal traineeship in Berlin and Chicago 1997 – 1999, Master program “International Studies in Intellectual Property Law” in Exeter, London and Dresden 2000 – 2001, Doctorate in Law at Technical University Dresden 2004, German attorney-at-law since 2000 in Berlin, Frankfurt and Munich, certified specialist IP lawyer since 2007, with HOFFMANN EITLE since 2008.


  • Empfohlen/ gelistet z.B. von Juve Rechtsmarkt (häufig empfohlener Anwalt seit 2007)
  • iam 1000
  • "Niels Hölder combines technical and legal skills to provide sophisticated representation in life science mandates"

  • Who’s Who Legal Germany
  • "Niels Hölder is a well-established patent litigator in the market who is particularly praised for his impressive work across the pharma sector"

  • IP Patent Star Germany, Managing Intellectual Property (2019 & 2020)